Jochen Reiser, MD, PhD is the chairman of the Department of Internal Medicine at Rush University Medical Center and the Ralph C. Brown, MD Professor of Medicine at Rush University.
Reiser is a world-renowned research leader in the field of kidney disease, with a heavy focus on molecular biology and genetics. He has published 200 papers, many of them in the highest-impact journals. His contributions range from identification of circulating factor suPAR in kidney diseases such as focal segmental glomerulosclerosis, and other forms of chronic kidney disease, or CKD. His work started new research fields and significantly advanced new treatment options for renal diseases. Reiser directs a NIH-funded research laboratory in biomedical investigation of the kidney. He is a member of the American Society for Clinical Investigation, the American Clinical and Climatological Society, the Association of American Physicians and Germany’s National Academy of Sciences, Leopoldina.
Reiser graduated from the Ruprecht Karls University of Heidelberg, Germany, and served his residency in internal medicine at the Albert Einstein College of Medicine in New York. He completed his fellowship in nephrology at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School in Boston. He then was an assistant professor at Harvard Medical School and the founding director of the program in glomerular disease at the Massachusetts General Hospital.
Prior to arriving at Rush in September 2012, Reiser was a professor of medicine, anatomy and cell biology, vice chairman for research in the department of medicine, and chief of the division of nephrology and hypertension at University of Miami Leonard M. Miller School of Medicine. There, he also served as the interim chairman of medicine.
For a summary of Reiser’s scientific work, please read Hall SS, Omen in the blood, Science 20 Apr 2018: Vol. 360, Issue 6386, pp. 254-258 DOI: 10.1126/science.360.6386.254
